Editas Medicine Inc Asset Turnover Ratio (EDIT), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Editas Medicine Inc   (NASDAQ: EDIT)
 

Editas Medicine Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Editas Medicine Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.24 in the third quarter (Sep 30 2026)

Within sector 35 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 2763 to 2876.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EDIT Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change 14.62 % 17.46 % -43.36 % -44.61 % -38.41 %
Y / Y Revenue Change 37.41 % 232.31 % -39.22 % -19.16 % 12265.57 %
Asset Turnover Ratio (TTM) 0.24 0.24 0.21 0.19 0.18
EDIT's Total Ranking # 2876 # 2763 # 1292 # 0 #
Seq. Asset Change -6.51 % 65.62 % -21.07 % -6.22 % -4.19 %
Seq. Revenue Change -12.83 % 319.99 % -88.56 % 228 % 110.82 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 36
Healthcare Sector # 414
Overall Market # 2876

Asset Turnover Ratio Statistics
High Average Low
0.24 0.09 0.02
(Jun 30 2026)   (Jun 30 2017)




EDIT Company Profile • Back to EDIT Efficiency Comparisons • Compare EDIT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Conmed Corporation  0.59 $ 1,369.288  Millions$ 2,311.365  Millions
Carlsmed Inc   0.59 $ 71.084  Millions$ 120.590  Millions
Bruker Corporation  0.58 $ 3,512.500  Millions$ 6,063.325  Millions
Iqvia Holdings Inc   0.58 $ 17,311.000  Millions$ 29,993.500  Millions
Merit Medical Systems Inc  0.58 $ 1,612.236  Millions$ 2,798.433  Millions
Gilead Sciences Inc   0.57 $ 30,988.000  Millions$ 54,017.750  Millions
Haemonetics Corporation  0.57 $ 1,382.737  Millions$ 2,415.705  Millions
Avantor Inc   0.57 $ 6,635.600  Millions$ 11,670.900  Millions
Bristol myers Squibb Company  0.57 $ 50,033.000  Millions$ 88,230.000  Millions
Rigel Pharmaceuticals Inc  0.56 $ 288.213  Millions$ 515.786  Millions
Stryker Corp  0.56 $ 26,300.000  Millions$ 47,328.000  Millions
Mannkind Corporation  0.55 $ 413.370  Millions$ 747.876  Millions
Icu Medical Inc  0.55 $ 2,183.556  Millions$ 3,994.839  Millions
Emergent Biosolutions Inc   0.55 $ 649.100  Millions$ 1,187.750  Millions
Bionano Genomics Inc   0.54 $ 31.085  Millions$ 58.068  Millions
Integer Holdings Corporation  0.54 $ 1,825.122  Millions$ 3,409.958  Millions
Vanda Pharmaceuticals Inc   0.53 $ 229.278  Millions$ 429.317  Millions
Ge Healthcare Technologies Inc   0.53 $ 19,878.000  Millions$ 37,412.000  Millions
Transmedics Group Inc   0.53 $ 727.650  Millions$ 1,371.382  Millions
Orthopediatrics Corp  0.52 $ 263.665  Millions$ 507.824  Millions
Cryo cell International Inc   0.51 $ 31.127  Millions$ 61.406  Millions
Johnson and Johnson  0.50 $ 99,335.000  Millions$ 199,647.500  Millions
Syndax Pharmaceuticals Inc   0.48 $ 289.431  Millions$ 599.674  Millions
Abbvie Inc   0.48 $ 66,014.000  Millions$ 138,304.500  Millions
Zevra Therapeutics Inc   0.48 $ 140.548  Millions$ 294.899  Millions
Boston Scientific Corporation  0.47 $ 21,070.000  Millions$ 44,675.250  Millions
Organon and Co   0.47 $ 6,111.000  Millions$ 13,110.500  Millions
Clearpoint Neuro Inc   0.47 $ 45.493  Millions$ 97.658  Millions
Abbott Laboratories  0.47 $ 48,229.000  Millions$ 103,651.000  Millions
Integra Lifesciences Holdings Corp  0.47 $ 1,656.786  Millions$ 3,562.754  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.